A Win For Plus Therapeutics, Inc.

Plus Therapeutics, Inc. (PSTV:NASDAQ) rocketted at $0.32, a gain of 68.4%. On Wed, Jun 25, 2025, PSTV:NASDAQ hit a New 2-Week Intraday High of $0.44. The stock got featured on our News Catalysts scanner on Wed, Jun 25, 2025 at 06:30 PM in the 'INVESTOR UPDATE' category. From Wed, Jun 11, 2025, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Wed, Jun 25, 2025 at $0.44 with a volume of 705M+.
About Plus Therapeutics, Inc. (PSTV:NASDAQ)
Cytori Therapeutics Inc is a specialty therapeutics company. It focuses to provide meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers. The company has two therapeutic development platforms: Cytori Cell Therapy (CCT) and Cytori Nanomedicine. The CCT platform is based on the scientific discovery that the human adipose or fat tissue compartment is a source of a mixed population of stem, progenitor and regenerative cells. The Cytori Nanomedicine Platform features a versatile and novel protein-stabilized liposomal nanoparticle technology for drug encapsulation that provides the foundation to bring two drugs into early/ late-stage clinical trials.
Top 10 Gainers:
- Urgent.ly Inc. (ULY:NASDAQ), 82.37%
- Vor Biopharma Inc. (VOR:NASDAQ), 74.28%
- Plus Therapeutics, Inc. (PSTV:NASDAQ), 68.45%
- XCF Global Inc. (SAFX:NASDAQ), 32.75%
- Anbio Biotechnology (NNNN:NASDAQ), 32.18%
- QuantumScape Corporation (QS:NYSE), 30.95%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 29.25%
- F45 Training Holdings Inc. (FXLV:NYSE), 27.66%
- Lianhe Sowell International Group Ltd (LHSW:NASDAQ), 26.67%
- X3 Holdings Co., Ltd. (XTKG:NASDAQ), 26.56%